Theranexus' Series A Round

Theranexus raised a round of funding on November 18, 2014.

Theranexus is a unique clinical stage pharmaceutical company, has developed a versatile proprietary technology leading to first in class products to address severe unmet medical needs in brain disorde…

Articles about Theranexus' Series A Round: